Motiper

Motiper may be available in the countries listed below.

Ingredient matches for Motiper

Domperidone

Domperidone is reported as an ingredient of Motiper in the following countries:

• Bangladesh

International Drug Name Search

Revatio

Revatio is a brand name of sildenafil, approved by the FDA in the following formulation(s):

REVATIO (sildenafil citrate - solution; intravenous)

• 
  Manufacturer: PFIZER
  
  Approval date: November 18, 2009
  
  Strength(s): EQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML) ^[RLD]

REVATIO (sildenafil citrate - tablet; oral)

• 
  Manufacturer: PFIZER
  
  Approval date: June 3, 2005
  
  Strength(s): EQ 20MG BASE ^[RLD]

Has a generic version of Revatio been approved?

No. There is currently no therapeutically equivalent version of Revatio available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Revatio. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Pyrazolopyrimidinone antianginal agents
  Patent 5,250,534
  Issued: October 5, 1993
  Inventor(s): Bell; Andrew S. & Brown; David & Terrett; Nicholas K.
  Assignee(s): Pfizer Inc.
  Compounds of the formula: ##STR1## wherein R.sup.1 is H, C.sub.1 -C.sub.3 alkyl, C.sub.3 -C.sub.5 cycloalkyl or C.sub.1 -C.sub.3 perfluoroalkyl; R.sup.2 is H, C.sub.1 -C.sub.6 alkyl optionally substituted by OH, C.sub.1 -C.sub.3 alkoxy or C.sub.3 -C.sub.6 cycloalkyl, or C.sub.1 -C.sub.3 perfluoroalkyl; R.sup.3 is C.sub.1 -C.sub.6 alkyl, C.sub.3 -C.sub.6 alkenyl, C.sub.3 -C.sub.6 alkynyl, C.sub.3 -C.sub.7 cycloalkyl, C.sub.1 -C.sub.6 perfluoroalkyl or (C.sub.3 -C.sub.6 cycloalkyl)C.sub.1 -C.sub.6 alkyl; R.sup.4 taken together with the nitrogen atom to which it is attached completes a pyrrolidinyl, piperidino, morpholino, or 4-N-(R.sup.6)-piperazinyl group; R.sup.5 is H, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.3 alkoxy, NR.sup.7 R.sup.8, or CONR.sup.7 R.sup.8 ; R.sup.6 is H, C.sub.1 -C.sub.6 alkyl, (C.sub.1 -C.sub.3 alkoxy) C.sub.2 - C.sub.6 alkyl, hydroxy C.sub.2 -C.sub.6 alkyl, (R.sup.7 R.sup.8 N)C.sub.2 -C.sub.6 alkyl, (R.sup.7 R.sup.8 NCO)C.sub.1 -C.sub.6 alkyl, CONR.sup.7 R.sup.8, CSNR.sup.7 R.sup.8 or C(NH)NR.sup.7 R.sup.8 ; R.sup.7 and R.sup.8 are each independently H, C.sub.1 -C.sub.4 alkyl, (C.sub.1 -C.sub.3 alkoxy)C.sub.2 -C.sub.4 alkyl or hydroxy C.sub.2 -C.sub.4 alkyl; and pharmaceutically acceptable salts thereof, are selective cGMP PDE inhibitors useful in the treatment of cardiovascular disorders such as angina, hypertension, heart failure and atherosclerosis.
  
  Patent expiration dates:
  
  
  • March 27, 2012
    
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  
  
  • September 27, 2012
    
    ✓ 
    Pediatric exclusivity
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • May 7, 2012 - TREATMENT OF PULMONARY ARTERIAL HYPERTENSION INDICATION EXPANDED TO INCLUDE DELAY IN CLINICAL WORSENING
  
  
  • November 7, 2012 - PEDIATRIC EXCLUSIVITY
  
  
  • November 20, 2012 - NEW DOSAGE FORM
  
  
  • May 20, 2013 - PEDIATRIC EXCLUSIVITY
  
  

See also...

• Revatio Consumer Information (Drugs.com)
• Revatio Consumer Information (Wolters Kluwer)
• Revatio Injection Consumer Information (Wolters Kluwer)
• Revatio Consumer Information (Cerner Multum)
• Revatio Advanced Consumer Information (Micromedex)
• Revatio Intravenous Advanced Consumer Information (Micromedex)
• Sildenafil Consumer Information (Wolters Kluwer)
• Sildenafil Injection Consumer Information (Wolters Kluwer)
• Sildenafil Consumer Information (Cerner Multum)
• Sildenafil Advanced Consumer Information (Micromedex)
• Sildenafil Intravenous Advanced Consumer Information (Micromedex)
• Sildenafil Citrate AHFS DI Monographs (ASHP)

Clorhexidina Sanitas

Clorhexidina Sanitas may be available in the countries listed below.

Ingredient matches for Clorhexidina Sanitas

Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Clorhexidina Sanitas in the following countries:

• Italy

International Drug Name Search

Enalek

Enalek may be available in the countries listed below.

Ingredient matches for Enalek

Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalek in the following countries:

• Czech Republic

International Drug Name Search

Ezeta

Ezeta may be available in the countries listed below.

Ingredient matches for Ezeta

Ezetimibe

Ezetimibe is reported as an ingredient of Ezeta in the following countries:

• Bangladesh

International Drug Name Search

Rilast Forte Turbuhaler Singad

Rilast Forte Turbuhaler Singad may be available in the countries listed below.

Ingredient matches for Rilast Forte Turbuhaler Singad

Budesonide

Budesonide is reported as an ingredient of Rilast Forte Turbuhaler Singad in the following countries:

• Denmark

Formoterol

Formoterol fumarate dihydrate (a derivative of Formoterol) is reported as an ingredient of Rilast Forte Turbuhaler Singad in the following countries:

• Denmark

International Drug Name Search

Normonal

Normonal may be available in the countries listed below.

Ingredient matches for Normonal

Tripamide

Tripamide is reported as an ingredient of Normonal in the following countries:

• Japan


• Thailand

International Drug Name Search

Interferon Alfa-n3

In the US, Interferon Alfa-n3 (interferon alfa-n3 systemic) is a member of the drug class interferons and is used to treat Condylomata Acuminata.

US matches:

• Interferon Alfa-n3 Solution


• Interferon alfa-n3

Ingredient matches for Interferon Alfa-n3

Interferon alfa

Interferon Alfa-n3 (USAN) is also known as Interferon alfa (Rec.INN)

International Drug Name Search

Glossary

Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.